Form 4 for TARA Protara Therapeutics, Inc.
Accepted 2024-01-23 00:00:00 ET · period of report 2024-01-19 · accession 0001213900-24-005726 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-23 | 2024-01-19 | TARA | Bandari Jathin | Chief Medical Off | A - Grant | $0.00 | +23.0K | 59.6K | +63% | $0 |
| D | 2024-01-23 | 2024-01-19 | TARA | Bandari Jathin | Chief Medical Off | F - Tax | $1.91 | -2,879 | 56.7K | -5% | -$5,499 |
| D | 2024-01-23 | 2024-01-19 | TARA | Bandari Jathin | Chief Medical Off | A - Grant | $0.00 | +137.0K | 137.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-19 | A | A | 23,000 | $0.00 | 59,583 | D | — | — | (F1) The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one-third installments on the first, second and third anniversaries of January 19, 2024. |
| 2 | Common | Common Stock | 2024-01-19 | F | D | 2,879 | $1.91 | 56,704 | D | — | — | (F3) Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 19, 2023. |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-01-19 | A | A | 137,000 | $0.00 | 137,000 | D | $1.91 · — to 2034-01-18 | 137,000 Common Stock | (F2) 25% of the shares vest on the one year anniversary of January 19, 2024 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date. |